Dear all, this week on Thursday March13, 15.15-16 in F202 there will be a seminar by Associate professor Daniela Ungureanu from Research Unit of Disease networks, Faculty of Biochemistry and Molecular Medicine, University of Oulu. The title of the seminar is: Single-cell transcriptomics of drug resistance in cancer and beyond. More about Dr. Ungureanu´s research: "My research focuses on understanding the signaling networks controlled by receptor tyrosine kinases (RTKs) during normal and aberrant cell growth such cancer. My goal is to assess the signaling pathways employed by Wnt-ligands binding RTKs in cancers and implement our research tools to determine to what extent targeting these molecules (alone or in combination) will improve cancer therapy. We are working with patient-derived tumor cells and perform molecular profiling such as assessments of cell growth in 2D and 3D, ex-vivo high throughput drug-responses analysis and transcriptomic profiling at the single cell level. This detailed information will help us to understand why/how these cancer cells respond differently to the various treatments, which could significantly improve cancer therapy in the future." Publications: https://pubmed.ncbi.nlm.nih.gov/?term=daniela+ungureanu&sort=date
Note the updated seminar programme below!
Welcome everybody! No registration required. Coffee is served during networking session 20 min before the presentation time. Field specific credits can be earned according to UniOGS recommendationshttps://www.oulu.fi/en/research/graduate-school/thesis-requirements-and-studies/study-requirements#accordion-control-recommendations-of-credits-for-different-activities- (attendance at scientific seminars for 10 hours: 0,5ECTS) If you would like to have separate discussions with the speaker, please contact Teija.luoto@oulu.fimailto:Teija.luoto@oulu.fi who will set up the meeting time. Organized by Biocenter Oulu, Health and Biosciences Doctoral Programme and PROFI6 Fibrobesity.
Kontinkangas Research Seminars Spring 2025_1003 You are welcome to suggest additional speakers.
Time and venue Speaker(s) Title January 23, 15.15-16 F101 Tommi Kajander Institute of Biotechnology, University of Helsinki Structural basis for CDNF function in BiP chaperone cycle regulation and unfolded protein response February 4 (Tuesday!), 15.15-16 H1091 Joan Chang Wellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine & Health, University of Manchester (Circadian) control of collagen homeostasis - new tools and insights March 13, 15.15-16 F202 Daniela Ungureanu Research Unit of Disease networks Faculty of Biochemistry and Molecular Medicine, University of Oulu Single-cell transcriptomics of drug resistance in cancer and beyond
April 3, 15.15-16 F202 Ian Mills Nuffield Department of Surgical Sciences, University of Oxford, UK Reflections on prostate cancer research April 10, Leena Palotie Hall, 101A 9-16 Biocenter Day Separate programme May 8, 15.15-16 F202 Juha Väyrynen Research Unit of Translational Medicine, Faculty of Medicine, University of Oulu Insights into colorectal cancer classification: morphology meets molecular biology
June 4-6, Linnanmaa 47th Association for Interdisciplinary Studies Conference (AIS2025) Shaping the Future in the Era of Polycrisis
https://app.eventos.fi/ais-conference-2025/website/496, registration required, Separate programme
Pirkko Huhtala, PhD Coordinator Biocenter Oulu, University of Oulu e-mail: pirkko.huhtala@oulu.fimailto:pirkko.huhtala@oulu.fi tel: +358-294 486101, + 358-40 1897467 Street address: Room 476B, Aapistie 5A, FIN-90220 Oulu Mailing address: PO Box 5000, FIN-90014 University of Oulu, Finland www.oulu.fi/biocenterhttp://www.oulu.fi/biocenter
Today on Thursday!
Subject: Kontinkangas Research Seminar March 13, 15.15-16 in F202
Dear all, this week on Thursday March13, 15.15-16 in F202 there will be a seminar by Associate Professor Daniela Ungureanu from Research Unit of Disease networks, Faculty of Biochemistry and Molecular Medicine, University of Oulu. The title of the seminar is: Single-cell transcriptomics of drug resistance in cancer and beyond. Dr. Ungureanu´s research focuses on single-cell omics of drug-treated cells to establish a core pharmacotranscriptomics pipeline to uncover drug-responses in cancer cells and its technological applications. More about Dr. Ungureanu´s research: "My research focuses on understanding the signaling networks controlled by receptor tyrosine kinases (RTKs) during normal and aberrant cell growth such cancer. My goal is to assess the signaling pathways employed by Wnt-ligands binding RTKs in cancers and implement our research tools to determine to what extent targeting these molecules (alone or in combination) will improve cancer therapy. We are working with patient-derived tumor cells and perform molecular profiling such as assessments of cell growth in 2D and 3D, ex-vivo high throughput drug-responses analysis and transcriptomic profiling at the single cell level. This detailed information will help us to understand why/how these cancer cells respond differently to the various treatments, which could significantly improve cancer therapy in the future." .
https://oulu.fi/en/research-groups/precision-oncology-ovarian-cancer Publications: https://pubmed.ncbi.nlm.nih.gov/?term=daniela+ungureanu&sort=date
Note the updated seminar programme below!
Welcome everybody! No registration required. Coffee is served during networking session 20 min before the presentation time. Field specific credits can be earned according to UniOGS recommendationshttps://www.oulu.fi/en/research/graduate-school/thesis-requirements-and-studies/study-requirements#accordion-control-recommendations-of-credits-for-different-activities- (attendance at scientific seminars for 10 hours: 0,5ECTS) If you would like to have separate discussions with the speaker, please contact Teija.luoto@oulu.fimailto:Teija.luoto@oulu.fi who will set up the meeting time. Organized by Biocenter Oulu, Health and Biosciences Doctoral Programme and PROFI6 Fibrobesity.
Kontinkangas Research Seminars Spring 2025_1003 You are welcome to suggest additional speakers. Time and venue Speaker(s) Title January 23, 15.15-16 F101 Tommi Kajander Institute of Biotechnology, University of Helsinki Structural basis for CDNF function in BiP chaperone cycle regulation and unfolded protein response February 4 (Tuesday!), 15.15-16 H1091 Joan Chang Wellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine & Health, University of Manchester,
(Circadian) control of collagen homeostasis - new tools and insights March 13, 15.15-16 F202 Daniela Ungureanu Research Unit of Disease networks Faculty of Biochemistry and Molecular Medicine, University of Oulu Single-cell transcriptomics of drug resistance in cancer and beyond
March 27, 15.15-16 F202 Elizabeth Tanner School of Engineering and Materials Science, Queen Mary University of London, London, UK Developing Bone Replacement Composites April 3, 15.15-16 F202 Ian Mills Nuffield Department of Surgical Sciences, University of Oxford, UK Reflections on prostate cancer research April 10, Leena Palotie Hall, 101A 8.30-16 Biocenter Day Mode the Code - Innovations in Gene Therapy Separate programme May 8, 15.15-16 F202 Juha Väyrynen Research Unit of Translational Medicine, Faculty of Medicine, University of Oulu Insights into colorectal cancer classification: morphology meets molecular biology
June 4-6, Linnanmaa 47th Association for Interdisciplinary Studies Conference (AIS2025) Shaping the Future in the Era of Polycrisis
https://app.eventos.fi/ais-conference-2025/website/496, registration required, Separate programme
Pirkko Huhtala, PhD Coordinator Biocenter Oulu, University of Oulu e-mail: pirkko.huhtala@oulu.fimailto:pirkko.huhtala@oulu.fi tel: +358-294 486101, + 358-40 1897467 Street address: Room 476B, Aapistie 5A, FIN-90220 Oulu Mailing address: PO Box 5000, FIN-90014 University of Oulu, Finland www.oulu.fi/biocenterhttp://www.oulu.fi/biocenter
-
Pirkko Huhtala